Nanologica AB (NICA) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.417x

Based on the latest financial reports, Nanologica AB (NICA) has a cash flow conversion efficiency ratio of -0.417x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-9.45 Million ≈ $-1.02 Million USD) by net assets (Skr22.64 Million ≈ $2.44 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Nanologica AB - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Nanologica AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read NICA current and long-term liabilities for a breakdown of total debt and financial obligations.

Nanologica AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nanologica AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Davis Commodities Limited Ordinary Shares NASDAQ:DTCK	-0.327x
Tarapur Transformers Limited NSE:TARAPUR	1.083x
Avricore Health Inc V:AVCR	-0.236x
Vestand Inc. NASDAQ:VSTD	-0.192x
Hubify Ltd AU:HFY	0.055x
Maple Peak Investments Inc V:MAP	-0.057x
Mint Corp V:MIT	0.055x
Auction Technology Group PLC LSE:ATG	0.068x

Annual Cash Flow Conversion Efficiency for Nanologica AB (2015–2025)

The table below shows the annual cash flow conversion efficiency of Nanologica AB from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see Nanologica AB market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr22.64 Million ≈ $2.44 Million	Skr-39.88 Million ≈ $-4.29 Million	-1.761x	-61.68%
2024-12-31	Skr74.11 Million ≈ $7.98 Million	Skr-80.73 Million ≈ $-8.69 Million	-1.089x	-105.77%
2023-12-31	Skr-1.90 Million ≈ $-204.26K	Skr-35.85 Million ≈ $-3.86 Million	18.887x	+3155.69%
2022-12-31	Skr73.16 Million ≈ $7.87 Million	Skr-45.22 Million ≈ $-4.87 Million	-0.618x	+31.41%
2021-12-31	Skr51.60 Million ≈ $5.55 Million	Skr-46.49 Million ≈ $-5.00 Million	-0.901x	-93.29%
2020-12-31	Skr92.97 Million ≈ $10.00 Million	Skr-43.34 Million ≈ $-4.66 Million	-0.466x	+83.33%
2019-12-31	Skr4.12 Million ≈ $443.48K	Skr-11.52 Million ≈ $-1.24 Million	-2.796x	-466.33%
2018-12-31	Skr23.71 Million ≈ $2.55 Million	Skr-11.71 Million ≈ $-1.26 Million	-0.494x	+95.87%
2017-12-31	Skr1.94 Million ≈ $208.60K	Skr-23.19 Million ≈ $-2.50 Million	-11.965x	-1036.92%
2016-12-31	Skr22.03 Million ≈ $2.37 Million	Skr-23.19 Million ≈ $-2.50 Million	-1.052x	-82.15%
2015-12-31	Skr24.14 Million ≈ $2.60 Million	Skr-13.95 Million ≈ $-1.50 Million	-0.578x	--

About Nanologica AB

ST:NICA Sweden Biotechnology

Market Cap

$5.12 Million

Skr47.60 Million SEK

Market Cap Rank

#28320 Global

#640 in Sweden

Share Price

Skr0.53

Change (1 day)

+0.75%

52-Week Range

Skr0.35 - Skr1.98

All Time High

Skr19.15